找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Accelerated Path to Cures; Josep Bassaganya-Riera Book 2018 Springer International Publishing AG, part of Springer Nature 2018 immunoinfor

[復制鏈接]
查看: 11720|回復: 36
樓主
發(fā)表于 2025-3-21 16:35:24 | 只看該作者 |倒序瀏覽 |閱讀模式
期刊全稱Accelerated Path to Cures
影響因子2023Josep Bassaganya-Riera
視頻videohttp://file.papertrans.cn/144/143626/143626.mp4
發(fā)行地址Details the role of modeling and computational approaches in precision medicine.Highlights the progress towards precision medicine.Advances Path to Cures
圖書封面Titlebook: Accelerated Path to Cures;  Josep Bassaganya-Riera Book 2018 Springer International Publishing AG, part of Springer Nature 2018 immunoinfor
影響因子.Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation .in silico. human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures.?.
Pindex Book 2018
The information of publication is updating

書目名稱Accelerated Path to Cures影響因子(影響力)




書目名稱Accelerated Path to Cures影響因子(影響力)學科排名




書目名稱Accelerated Path to Cures網(wǎng)絡公開度




書目名稱Accelerated Path to Cures網(wǎng)絡公開度學科排名




書目名稱Accelerated Path to Cures被引頻次




書目名稱Accelerated Path to Cures被引頻次學科排名




書目名稱Accelerated Path to Cures年度引用




書目名稱Accelerated Path to Cures年度引用學科排名




書目名稱Accelerated Path to Cures讀者反饋




書目名稱Accelerated Path to Cures讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-22 00:01:49 | 只看該作者
https://doi.org/10.1007/978-3-658-34682-9 C-like 2 (LANCL2) pathway and the development of LANCL2-based oral small molecule therapeutics for inflammatory bowel disease (IBD). From the application of docking studies to screen new chemical entities to the development of next-generation . human clinical trials.
板凳
發(fā)表于 2025-3-22 04:03:19 | 只看該作者
地板
發(fā)表于 2025-3-22 08:20:32 | 只看該作者
5#
發(fā)表于 2025-3-22 10:46:54 | 只看該作者
Introduction: What We Owe the Child,such as IBD. Finally, we show how advancements in the field of nutritional immunology can be used to enable the development of predictive, preventive, and personalized path to safer and more effective drugs.
6#
發(fā)表于 2025-3-22 14:40:49 | 只看該作者
Path to Cures.Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the
7#
發(fā)表于 2025-3-22 17:32:14 | 只看該作者
8#
發(fā)表于 2025-3-22 23:52:14 | 只看該作者
Front Matterst zutreffend, umfassend und rasch festzustellen. Dies gilt ebenso für Entscheidungen über Therapien oder die Erstellung von Gutachten wie für den Forschungsbereich. Ob aber klassifikatorische Ans?tze hier mehr nützen oder mehr schaden, wurde lange und teilweise erbittert diskutiert.
9#
發(fā)表于 2025-3-23 05:05:22 | 只看該作者
10#
發(fā)表于 2025-3-23 07:40:55 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 07:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
阿克陶县| 汉中市| 民和| 廊坊市| 天等县| 沾益县| 屯昌县| 澄迈县| 梁平县| 寿光市| 高淳县| 那曲县| 瑞金市| 永清县| 铜川市| 闽侯县| 丽水市| 平江县| 长垣县| 乐业县| 高雄县| 隆德县| 忻城县| 胶州市| 日土县| 锦州市| 辽阳市| 罗源县| 阳山县| 旬邑县| 邯郸县| 盱眙县| 广宁县| 牟定县| 昭苏县| 通州区| 舒兰市| 苏尼特右旗| 尼勒克县| 崇文区| 秦皇岛市|